Patience13 Jan 2021 09:40
I think the issue with Hemo at the moment is that there are other gains achievable elsewhere in the short term. Hemo is gradually becoming more de-risked as it's pipeline if products mature therefore it should be more attractive to hold as it gains deals and calls orations. Therefore, I expect Hemo to become a £1 + share during the next couple of years.